TERNS
Live / Applied — Suspended — suspension check completed, case still suspended (as of 25 Jan 2026)
What this means for you
Not registered yet, but its 09 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98740258
- Mark type
- Stylized text
- Filed
- 09 Sept 2024
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; Pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; Peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders.
- Class 042 — Scientific and technological services: Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; Research and development services in the field of pharmaceutical and biologic preparations; Research and development services in the field of oncology-related diseases and disorders; Research and development services in the field of metabolic-related diseases and disorders; Research and development services in the field of endocrine-related diseases and disorders; Research and development services in the fields of diabetes and obesity-related diseases and disorders; Research and development services in the field of peptide pharmaceutical preparations; Providing medical and scientific research information in the field of small-molecule drugs; Providing medical and scientific research information in the field of clinical trials and post-market trials; Providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders.
Owner
- Terns Pharmaceuticals, Inc., Foster City, CA, US
Prosecution history
- 25 Jan 2026 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 24 Jul 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 24 Jul 2025 — LETTER OF SUSPENSION E-MAILED
- 24 Jul 2025 — SUSPENSION LETTER WRITTEN
- 11 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Mar 2025 — NON-FINAL ACTION E-MAILED
- 11 Mar 2025 — NON-FINAL ACTION WRITTEN
- 11 Mar 2025 — ASSIGNED TO EXAMINER
- 09 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED